• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Peripheral stent DES B.E. – Cre8™ BTK
cobalt-chromiumdrug eluting

peripheral stent
peripheral stent
peripheral stent
peripheral stent
peripheral stent
Add to favorites
Compare this product
 

Characteristics

Type
peripheral
Material
cobalt-chromium
Options
drug eluting
Diameter

2.25 mm, 2.75 mm, 3 mm, 3.5 mm, 4 mm
(0.089 in, 0.108 in, 0.118 in, 0.138 in, 0.157 in)

Length

12 mm, 16 mm, 20 mm, 31 mm, 46 mm
(0.472 in, 0.63 in, 0.787 in, 1.22 in, 1.811 in)

Description

Polymer-free Amphilimus (Sirolimus + organic acid) eluting BTK stent. Product key features: - Abluminal Reservoir Technology - Amphilimus™ formulation: Sirolimus + Fatty Acid - Bio Inducer Surface · Stent Diameter mm: 2,25mm, 2,5mm, 2,75mm, 3,0mm, 3,5mm, 4,0mm, 4,5mm · Stent Length mm: 8mm, 12mm, 16mm, 20mm, 25mm, 31mm, 38mm, 46mm · Catheter Length cm: 142cm For more info please refer to the Alvimedica website Polymer-free Amphilimus™ eluting stent for below the knee arteries. The absence of the polymer minimizes the risk of inflammation/thrombosis, while the propriety formulation enhances drug absorption. This may contribute to maximize results in diabetic patients. Controlled and directed drug elution by the Abluminal Reservoir Technology, without the use of any polymer. Maximized efficacy, especially in Diabetic Patients, due to the proprietary Amphilimus™ formulation, a combination of Sirolimus and Fatty Acid. Proven haemo/biocompatibility enabled by the Bio Inducer Surface, which accelerates the rate of endothelialization and reduces thrombogenicity.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.